IBD 2020: Right therapy, right patient, right time - Choosing wisely: Conclusions

J Gastroenterol Hepatol. 2021 Apr:36 Suppl 1:35-36. doi: 10.1111/jgh.15461.

Author

Miles Sparrow¹

Affiliation

¹ The Alfred Hospital and Monash University, Melbourne, Australia.

PMID: 33817856
DOI: 10.1111/jgh.15461

No abstract available

MeSH terms

Adrenal Cortex Hormones / administration & dosage
Adrenal Cortex Hormones / adverse effects
Biomarkers / analysis
Clinical Decision-Making*
Drug Monitoring
Feces / chemistry
Humans
Inappropriate Prescribing
Inflammatory Bowel Diseases / diagnosis*
Inflammatory Bowel Diseases / therapy*
Leukocyte L1 Antigen Complex / analysis
Medication Errors / prevention & control
Molecular Targeted Therapy
Monitoring, Physiologic
Precision Medicine
Tumor Necrosis Factor-alpha
Unnecessary Procedures

Substances

Adrenal Cortex Hormones
Biomarkers
Leukocyte L1 Antigen Complex
Tumor Necrosis Factor-alpha